Dr. Katz presents the novel concept of “morphometry”, the groundbreaking ability to quantify morphological parameters at scale using Full-Field technology and AI. He will share the results from recent MDS and CAR-T cell therapy morphology research performed at TASMC, illustrating how accurate measurement of the morphological parameters could enhance diagnostic precision and yield new, morphology-based biomarkers.
Full-Field Cell Morphology™ represents significant progress in standardization, efficiency, remote workflow capability, and scalability of hematological examination. It fundamentally changes laboratory practice and closes the gap between the manual and digital peripheral blood smear review.
Evaluation of the first high-resolution full-field viewing of peripheral blood specimens combined with artificial intelligence-based morphological analysis.